Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

LivaNova to Host Conference Call for Third-Quarter 2016 Results

LivaNova PLC
Posted on: 04 Oct 16

LONDON, Oct. 04, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company"), a market-leading medical technology company, will host a conference call to discuss its third quarter results on Wednesday, November 2, 2016 at 8:00 a.m. Central Time (1:00pm GMT).

The Company will release its third-quarter results earlier that morning, before the open of the U.S. financial markets.

A live webcast of the conference call will be available on the Investor Relations section of LivaNova's website at .  To listen to the conference call by telephone, dial 844-239-5285 (if dialing from within the U.S.) or 512-961-6524 (if dialing from outside the U.S.).  The conference ID is 87431578.  Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast.  A replay will be available on the LivaNova website for 90 days following the call. 

About LivaNova
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.  LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems.  The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K. With a presence in more than 100 countries, LivaNova operates as three business units: Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), respectively.

LivaNova is listed on NASDAQ and is admitted to the standard listing segment of the Official List of the UK's Financial Conduct Authority and to trading on the London Stock Exchange (LSE) under the ticker symbol "LIVN".

For more information, please visit , or contact:

Investor Relations and Media
Karen King
Vice President, Investor Relations & Corporate Communications
Phone:  +1 (281) 228-7262
Fax:  +1 (281) 218-9332

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: LivaNova PLC via GlobeNewswire

Last updated on: 05/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.